20年间接受肝切除术患者中非酒精性脂肪性肝病相关肝细胞癌的时间趋势、临床模式与结局
该研究纳入1995-2014年连续323例经组织学确诊并接受肝切除术的肝细胞癌患者,其中12%为非酒精性脂肪性肝病相关肝细胞癌。非酒精性脂肪性肝病相关肝细胞癌患病率从1995-1999年的2.6%升至2010-2014年的19.5%(P=.003),且63%的病例无桥接纤维化/肝硬化(与其他病因相比P<.001)。其复发时间和生存与其他病因肝细胞癌相似。
要点
- 20年间可切除肝细胞癌中非酒精性脂肪性肝病相关肝细胞癌患病率从2.6%升至19.5%(P=.003)。
- 非酒精性脂肪性肝病相关肝细胞癌63%无桥接纤维化/肝硬化(与其他病因相比P<.001)。
- 非酒精性脂肪性肝病相关肝细胞癌复发时间和生存与其他病因肝细胞癌相似。
核心结论
- 过去20年可切除肝细胞癌中非酒精性脂肪性肝病相关肝细胞癌大幅增加,现已成为无或仅有轻微纤维化肝细胞癌的首位病因。
- 非酒精性脂肪性肝病患者年龄更大、肿瘤更大,但生存和复发率与其他病因一样严重。
研究设计与样本
- 连续纳入20年期间(1995-2014年)经组织学确诊并接受肝切除术的肝细胞癌患者,共323例,其中12%为非酒精性脂肪性肝病相关肝细胞癌。
- 非酒精性脂肪性肝病基于既往或当前肥胖或糖尿病暴露且无其他慢性肝病病因诊断。
主要发现
- 非酒精性脂肪性肝病相关肝细胞癌患病率从1995-1999年的2.6%升至2010-2014年的19.5%(P=.003),代谢危险因素患病率从28%升至52%(P=.017),而丙型肝炎肝细胞癌从43.6%降至19.5%(P=.003)。
- 非酒精性脂肪性肝病相关肝细胞癌63%无桥接纤维化/肝硬化(与其他病因相比P<.001)。
- 非酒精性脂肪性肝病组内F0-F2与F3-F4患者肿瘤特征相似,除单结节比例更高(95% vs 54%,P<.01)。
- 53%患者肿瘤复发,40%死亡;非酒精性脂肪性肝病相关肝细胞癌与其他病因肝细胞癌的复发时间和生存相似。
- 卫星结节、肿瘤大小、微血管侵犯和男性而非病因与复发独立相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is an increasing cause of hepatocellular carcinoma (HCC) worldwide. NAFLD-HCC often occurs in noncirrhotic liver raising important surveillance issues. AIM: To determine the temporal trends for prevalence, clinical characteristics and outcomes of NAFLD-HCC in patients undergoing liver resection. METHODS: Consecutive patients with histologically confirmed HCC who underwent liver resection over a 20-year period (1995-2014). NAFLD was diagnosed based on past or present exposure to obesity or diabetes without other causes of chronic liver disease. RESULTS: A total of 323 HCC patients were included, 12% with NAFLD. From 1995-1999 to 2010-2014, the prevalence of NAFLD-HCC increased from 2.6% to 19.5%, respectively, P = .003, and followed the temporal trends in the prevalence of metabolic risk factors (28% vs 52%, P = .017), while hepatitis C-HCC decreased (from 43.6% to 19.5%, P = .003). NAFLD-HCC occurred more frequently in the absence of bridging fibrosis/cirrhosis (63% of cases, P < .001 compared to other aetiologies). Within the NAFLD group, tumour characteristics were similar between F0-F2 and F3-F4 patients, except for a higher proportion of single nodules (95% vs 54%, P < .01). A total of 53% patients had tumour recurrence and 40% died. NAFLD-HCC had similar time to recurrence and survival as HCCs of other aetiologies. Satellite nodules, tumour size, microvascular invasion and male sex but not the aetiology were independently associated with recurrence. CONCLUSION: Non-alcoholic fatty liver disease increased substantially over the past 20 years among resectable HCCs. It is now the leading cause of HCC occuring without/or with only minimal fibrosis. NAFLD patients are older, with larger tumours while survival and recurrence rates are as severe as in other aetiologies.
引用
- Pais R, Fartoux L, Goumard C, et al. Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period. Aliment Pharmacol Ther. 2017. PMID: 28857208. doi:10.1111/apt.14261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。